- Home
- CERO vs OP Comparison
CERO vs OP Comparison
Compare CERO & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- OP
- Stock Information
- Founded
- CERO 2017
- OP 2021
- Country
- CERO United States
- OP Greece
- Employees
- CERO N/A
- OP N/A
- Industry
- CERO
- OP
- Sector
- CERO
- OP
- Exchange
- CERO Nasdaq
- OP Nasdaq
- Market Cap
- CERO 3.5M
- OP 5.3M
- IPO Year
- CERO N/A
- OP N/A
- Fundamental
- Price
- CERO $8.70
- OP $1.23
- Analyst Decision
- CERO Strong Buy
- OP
- Analyst Count
- CERO 2
- OP 0
- Target Price
- CERO $45.00
- OP N/A
- AVG Volume (30 Days)
- CERO 3.3M
- OP 9.4M
- Earning Date
- CERO 08-13-2025
- OP 08-06-2025
- Dividend Yield
- CERO N/A
- OP N/A
- EPS Growth
- CERO N/A
- OP N/A
- EPS
- CERO N/A
- OP N/A
- Revenue
- CERO N/A
- OP $25,702,000.00
- Revenue This Year
- CERO N/A
- OP N/A
- Revenue Next Year
- CERO N/A
- OP N/A
- P/E Ratio
- CERO N/A
- OP N/A
- Revenue Growth
- CERO N/A
- OP 35.58
- 52 Week Low
- CERO $6.71
- OP $0.63
- 52 Week High
- CERO $895.40
- OP $3.17
- Technical
- Relative Strength Index (RSI)
- CERO 46.62
- OP 46.07
- Support Level
- CERO $9.10
- OP $1.16
- Resistance Level
- CERO $9.73
- OP $1.67
- Average True Range (ATR)
- CERO 1.50
- OP 0.30
- MACD
- CERO -0.01
- OP -0.12
- Stochastic Oscillator
- CERO 10.78
- OP 4.43
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.